ENTITY

SciSparc (SPRC US)

83
Analysis
Health Care • Israel
SciSparc Ltd. provides pharmaceutical products. The Company develops cannabinoid technologies for treatment of central nervous system disorders. SciSparc serves customers worldwide.
more
•15 Jan 2025 10:29•Broker

US Inflation and 4Q24 Earnings Results

Technically, the SET Index is expected to weaken, with the support at 1,332/1,322 points and the resistance at 1,349/1,355 points. US: The 4Q24...

Logo
85 Views
Share
•10 Jan 2025 09:58•Broker

Today's Dominant Ideas

Technically, the SET Index is expected to move in a sideways-down pattern, with the support at 1,352/1,345 points and the resistance at...

Logo
87 Views
Share
•19 Nov 2024 09:57•Broker

First Meeting of the Economic Stimulus Policy Committee

Technically, the SET Index is expected to move up and down, with the resistance at 1,463/1,474 points and the support at 1,444/1,441 points...

Logo
92 Views
Share
•13 Nov 2024 10:07•Broker

Strategic Daily Picks

Technically, the SET Index is expected to move sideways down, with the support at 1,440 points (50-day EMA)/1,432 points and the resistance at...

Logo
88 Views
Share
bullish•Macroeconomics
•08 Oct 2024 12:50•Broker

Economic Update: Inflation in September 2024

There remains a possibility that the Monetary Policy Committee (MPC) may lower interest rates in the remainder of this year, despite market...

Logo
91 Views
Share
x